Envision Report

Published January 12, 2018

Regenerative Medicines Market- Size, Outlook, Trends and Forecasts (2018 – 2024)

Download Free Sample Report!

Regenerative medicine is a branch involved in the repair, replace and regenerate tissues and organs affected due to injury, disease or natural ageing process. These medicines can restore the functionality of cells and tissues and are used in various strategies like cell therapy, gene therapy, and tissue engineering. Many firms and industries are trying to develop and improve the technological approaches to increase the market.

Global Regenerative Medicines Market Segments size & growth:

The market is valued at USD 17.625 Billion in 2017 and is expected to reach USD 51.453 Billion by 2024 at a CAGR of 23.8%. The primary factors influencing the market growth are growing prevalence of chronic diseases such as bone and joint diseases and trauma emergencies, increasing the need for orthopaedic surgeries, innovation in stem cell therapy, technological innovations and tissue engineering.

Global Regenerative Medicines Market Segments share:

By application, the market is segmented into orthopaedic, oncology, diabetes, cardiology and central nervous system. Among this oncology is having the most significant share and fastest growth in the market. The market is majorly divided into products, application, therapy, material and agent type. By products, it is segmented into cell-based and acellular, and by therapy, the market is segmented into the cell, therapy, tissue and gene therapy. The application is segmented into orthopaedic, dermatology, cardiology, oncology and central nervous system. By material, the market is categorised into algae-derived alginate, synthetic polymer, polylactide- coglycolide, polyethylene glycol and hydrogels. Final segmentation is based on agent type it is into biologics, cell-based medical devices, and biopharmaceuticals. By geography, the market is predominant in Asia-Pacific, and it continues during the forecast period. North America is in its growing phase and is holding the largest in regenerative medicines market as the therapies are in the 3rd phase of clinical trials.

Global Regenerative Medicines Market Trends:

  • Recent acquisitions in biotechnology are leading the regenerative medical industry have favourable growth.
  • Medtronic acquired heart wave international which is a provider of technologies for mechanical circulatory support for patient’s treatment. This acquisition further is projected to have the company by broadening its products portfolio.

Global Regenerative Medicines Market Research Report Includes:

  • An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
  • To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
  • Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
  • Identifying DROC in the current market and their impact in altering the market dynamics.
  • Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
  • Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
  • The principal market players are:
  • CONMED Corporation
  • Anika Therapeutics Inc.
  • Zimmer Holdings Inc.
  • Medtronic Inc.
  • Vericel corporation

1. Introduction                               

1.1.   Executive Summary

1.2.   Market Definition

1.3.   The scope of the Study

2. Research Methodology

2.1.   Secondary Research

2.2.   Primary Research

2.3.   Analytics Tools & Model

2.4.   Economic Indicators

2.4.1.Base Year, Base Currency & Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

3. Market Analysis                               

3.1.   Industry Value Chain Analysis

3.2.   Porter’s Five Force Analysis

3.2.1 Bargaining Power of Suppliers

3.2.2 Bargaining Power of Buyers

3.2.3 Threat of Substitutes

3.2.4 Threat of New Entrants

3.2.5 Industry Rivalry (Competitive Environment)

3.3. PESTLE Analysis

3.3.1 Political

3.3.2 Economical

3.3.3 Social

3.3.4 Technological

3.3.5 Legal

3.3.6 Environmental

3.4. SWOT Analysis

3.4.1 Strengths

3.4.2 Weakness

3.4.3 Opportunities

3.4.4 Threats

3.4.5 Y-O-Y Analysis

4. Market Dynamics                               

4.1. Drivers

4.1.1 Increase in corporate partnerships to accelerate development and commercialise of regenerative medicine.

4.1.2 Increase in global healthcare expenditure.

4.1.3 Rapid growth in ageing population.

4.1.4. Prevalence of chronic diseases and genetic disorders.

4.2. Restraints

4.2.1 Cost of treatment.

4.2.2 Complex regeneration process.

4.2.3. Lack of guidelines.

4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.

4.3. Opportunities

4.3.1. Strong product pipeline.

4.3.2. Great Demand for organ transplantation.

4.4. Challenges

4.4.1 Stringent regulatory policies about stem cell technologies.

5. Global Regenerative Medicine Market – By Product

5.1 Introduction

5.2 Cell-based products

5.2.1 Allogeneic products

5.2.2 Autologous products

5.3 Acellular products

6. Global Regenerative Medicine Market – By Application

6.1 Introduction

6.2 Orthopaedic and musculoskeletal disorders

6.3 Dermatology

6.4 Cardiology

6.5 Central nervous system diseases

6.6 Oncology

6.7 Diabetes

6.8 Bone graft substitutes

6.9 Others

7. Global Regenerative Medicine Market – By Therapy

7.1 Introduction

7.2 Cell therapy

7.3 Immunotherapy

7.4 Tissue therapy

7.5 Gene therapy

7.6 Others

8. Global Regenerative Medicine Market – By Material

8.1 Introduction

8.2 Algae-derived alginate

8.3 Synthetic polymer

8.4 Poly-lactide-coglycolide

8.5 Poly-ethylene glycol

8.6 Hydrogels

8.7 Others

9. Global Regenerative Medicine Market – by Agent type

9.1 Introduction

9.2 Biologics

9.2.1 Autologous fibroblasts

9.2.2 Hematopoietic stem and progenitor cells

9.3 Cell-based medical devices

9.3.1 Allogenic fibroblasts

9.3.2 Cell extraction

9.4 Biopharmaceuticals

9.4.1 Tricalcium phosphate

9.4.2 Osteogenic protein

10. Global Regenerative Medicine Market – By Geography

10.1 North America

10.1.1 Introduction

10.1.2 United States

10.1.3 Canada

10.1.4 Mexico

10.1.5 Others

10.2 Europe

10.2.1 Introduction

10.2.2 France

10.2.3 Germany

10.2.4 Italy

10.2.5 United Kingdom

10.2.6 Spain

10.2.7 Russia

10.2.8 Others

10.3 Asia-pacific

10.3.1 Introduction

10.3.2 China

10.3.3 Japan

10.3.4 India

10.3.5 Australia & New Zealand

10.3.6 Others

10.4 South America

10.4.1 Introduction

10.4.2 Brazil

10.4.3 Argentina

10.4.4 Others

10.5 The Middle East and Africa

10.5.1 Introduction

10.5.2 Saudi Arabia

10.5.3 Israel

10.5.4 UAE

10.5.5 Others

11. Global Regenerative Medicine Market – Company Profiles

11.1 Stryker Corporation

11.2 CONMED Corporation

11.3 Anika Therapeutics Inc.

11.4 Zimmer Holdings Inc.

11.5 Medtronic Inc.

11.6 Vericel corporation

11.7 Baxter International Inc.

11.8 Acelity

11.9 DePuy Synthes Inc.

11.10 StemCells Inc.

11.11 rthrex Inc.

11.12 rganogenesis

11.13 immer biomet holdings

11.14 uvasive

11.15 mith & Nephew PLC

11.16 integra lifesciences corporation

12. Global Regenerative Medicine Market – Competitive Landscape

12.1 Market Share Analysis

12.2 Strategies Adopted by top companies

12.3 Merges, Acquisitions, Collaborations & Agreements

13. Market Insights                               

13.1 Industry Experts Insights

13.2 Analysts Opinions

13.3 Investment Opportunities

14. Appendix                               

14.1 List of tables

14.2 List of figures

  • Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
  • Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
  • The Regional and Global Variety is taken care of in the report.
  • Year on Year basis generation of revenue is studied.
  • Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
  • The overview and the sustainability of the market are analyzed through SWOT.
  • DROC is recognized in the current market scenario and see how its effect on market dynamics.
  • The segment-level analysis in terms of type and technology.
  • The value chain analysis, value that's created and captured by a company is the profit margin.Value
  • Created and Captured – Cost of Creating that Value = Margin
  • An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
  • Basis on the depth of the study we approach using analytical tools
  • Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.


©2018 - Envision Inteligence | All Rights Reserved.